Echoiq Ltd (EIQ) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.300x

Based on the latest financial reports, Echoiq Ltd (EIQ) has a cash flow conversion efficiency ratio of -0.300x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.18 Million ≈ $-3.67 Million USD) by net assets (AU$17.27 Million ≈ $12.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Echoiq Ltd net asset quality index to measure how much of total assets are equity-financed.

Echoiq Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Echoiq Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check EIQ cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Echoiq Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Echoiq Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
COGNYTE SOFTWARE LTD
F:81M
0.087x
Autoneum Holding AG
SW:AUTN
0.178x
Shanghai Zhongyida Co Ltd A
SHG:600610
0.483x
Mobilicom Limited Warrants
NASDAQ:MOBBW
-0.038x
Talkspace Inc
NASDAQ:TALK
0.044x
C.E. Info Systems Limited
NSE:MAPMYINDIA
0.050x
TVS Supply Chain Solutions Limited
NSE:TVSSCS
0.221x
PNE AG
XETRA:PNE3
-0.170x

Annual Cash Flow Conversion Efficiency for Echoiq Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Echoiq Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Echoiq Ltd (EIQ) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$22.76 Million
≈ $16.10 Million
AU$-6.51 Million
≈ $-4.61 Million
-0.286x +50.67%
2023-12-31 AU$6.77 Million
≈ $4.79 Million
AU$-3.92 Million
≈ $-2.78 Million
-0.580x +13.35%
2022-12-31 AU$7.38 Million
≈ $5.22 Million
AU$-4.94 Million
≈ $-3.50 Million
-0.669x -107.63%
2021-12-31 AU$8.02 Million
≈ $5.67 Million
AU$-2.58 Million
≈ $-1.83 Million
-0.322x -121.48%
2020-12-31 AU$9.84 Million
≈ $6.96 Million
AU$-1.43 Million
≈ $-1.01 Million
-0.146x +58.81%
2019-12-31 AU$3.12 Million
≈ $2.21 Million
AU$-1.10 Million
≈ $-780.93K
-0.353x -181.18%
2018-12-31 AU$-464.69K
≈ $-328.80K
AU$-202.21K
≈ $-143.08K
0.435x -96.14%
2017-12-31 AU$-147.39K
≈ $-104.29K
AU$-1.66 Million
≈ $-1.18 Million
11.276x +267.83%
2016-12-31 AU$341.17K
≈ $241.40K
AU$-2.29 Million
≈ $-1.62 Million
-6.719x -1515.96%
2015-12-31 AU$-1.39 Million
≈ $-980.28K
AU$-657.38K
≈ $-465.14K
0.474x +991.19%
2014-12-31 AU$2.13 Million
≈ $1.51 Million
AU$-113.26K
≈ $-80.14K
-0.053x +24.46%
2013-12-31 AU$2.55 Million
≈ $1.80 Million
AU$-179.69K
≈ $-127.14K
-0.070x -80.57%
2012-12-31 AU$1.78 Million
≈ $1.26 Million
AU$-69.52K
≈ $-49.19K
-0.039x --

About Echoiq Ltd

AU:EIQ Australia Health Information Services
Market Cap
$649.97 Million
AU$918.60 Million AUD
Market Cap Rank
#10698 Global
#278 in Australia
Share Price
AU$1.39
Change (1 day)
-7.33%
52-Week Range
AU$0.17 - AU$1.75
All Time High
AU$1.75
About

Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company was formerly known as Houston We Have Limited and changed its name to E… Read more